Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of HCA Holdings, Inc. (NYSE:HCA) by 4.1% during the second quarter, according to its most recent disclosure with the SEC. The firm owned 244,430 shares of the company’s stock after buying an additional 9,630 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank owned approximately 0.07% of HCA Holdings worth $21,314,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Oxbow Advisors LLC acquired a new stake in HCA Holdings during the first quarter valued at approximately $1,628,000. Greenleaf Trust acquired a new stake in HCA Holdings during the first quarter valued at approximately $218,000. BB&T Corp boosted its stake in HCA Holdings by 4.1% in the first quarter. BB&T Corp now owns 100,598 shares of the company’s stock valued at $8,952,000 after buying an additional 3,977 shares in the last quarter. Exane Derivatives acquired a new stake in HCA Holdings during the first quarter valued at approximately $2,787,000. Finally, Sumitomo Mitsui Asset Management Company LTD boosted its stake in HCA Holdings by 7.9% in the first quarter. Sumitomo Mitsui Asset Management Company LTD now owns 25,080 shares of the company’s stock valued at $2,231,000 after buying an additional 1,833 shares in the last quarter. 73.76% of the stock is owned by institutional investors.

HCA Holdings, Inc. (HCA) opened at 79.51 on Monday. The company has a market cap of $28.72 billion, a price-to-earnings ratio of 10.66 and a beta of 0.67. The firm has a 50-day moving average price of $81.48 and a 200 day moving average price of $84.16. HCA Holdings, Inc. has a one year low of $67.00 and a one year high of $91.03.

HCA Holdings (NYSE:HCA) last released its quarterly earnings results on Tuesday, July 25th. The company reported $1.75 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.80 by $0.05. HCA Holdings had a negative return on equity of 48.08% and a net margin of 6.64%. The firm had revenue of $10.73 billion during the quarter, compared to analysts’ expectations of $10.76 billion. During the same period in the prior year, the firm posted $1.66 earnings per share. HCA Holdings’s revenue for the quarter was up 4.0% compared to the same quarter last year. Equities analysts expect that HCA Holdings, Inc. will post $7.18 earnings per share for the current fiscal year.

WARNING: This story was originally published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this story on another website, it was stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this story can be viewed at https://theolympiareport.com/2017/08/28/zurcher-kantonalbank-zurich-cantonalbank-buys-9630-shares-of-hca-holdings-inc-hca.html.

Several research firms recently commented on HCA. Zacks Investment Research cut HCA Holdings from a “buy” rating to a “hold” rating in a research note on Friday, July 14th. BidaskClub cut HCA Holdings from a “hold” rating to a “sell” rating in a research note on Monday, July 24th. Argus began coverage on HCA Holdings in a research note on Wednesday, June 28th. They set a “buy” rating and a $100.00 target price for the company. Leerink Swann raised HCA Holdings from a “market perform” rating to an “outperform” rating and raised their target price for the stock from $92.00 to $100.00 in a research note on Tuesday, June 6th. Finally, Morgan Stanley began coverage on HCA Holdings in a research note on Tuesday, June 6th. They set an “equal weight” rating and a $90.00 target price for the company. One research analyst has rated the stock with a sell rating, five have issued a hold rating and thirteen have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $92.81.

In other HCA Holdings news, insider Jonathan B. Perlin sold 71,063 shares of HCA Holdings stock in a transaction on Thursday, June 22nd. The shares were sold at an average price of $86.00, for a total value of $6,111,418.00. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, insider Michael S. Cuffe sold 2,150 shares of HCA Holdings stock in a transaction on Tuesday, August 15th. The stock was sold at an average price of $79.88, for a total transaction of $171,742.00. Following the completion of the transaction, the insider now directly owns 12,363 shares in the company, valued at $987,556.44. The disclosure for this sale can be found here. Insiders sold 77,513 shares of company stock worth $6,651,455 over the last ninety days. Corporate insiders own 2.90% of the company’s stock.

About HCA Holdings

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Holdings, Inc. (NYSE:HCA).

Institutional Ownership by Quarter for HCA Holdings (NYSE:HCA)

Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.